Stolmár & Partner, ARNOLD RUESS and Meyerlustenberger Lachenal are pleased to invite you to attend our annual Pharma and Life Science Day to be held on 12 July 2019 in Schloss Suresnes in Munich.
As in previous years, high-calibre in-house practitioners and attorneys will present hot topics in Pharma and Life Sciences fresh from their desks. Our speakers are inter alia from Novartis International AG, Sanofi, MilliporeSigma, Stalicla S.A., Dr Reddy’s Laboratories SA, Paton Landespatentzentrum Thüringen an der TU Ilmenau, Egis Pharmaceuticals PLC, the European Patent Office and the District Court of Munich.
You will hear more about recent developments in the CRISPR/Cas IP landscape, implications of the Falsified Medicine Directive (FMD), SPC waivers and the Nagoya Protocol. In addition, we will update you on the most recent decisions in Pharma case law, explain the pitfalls of EU competition law and shed light on the question of purity as novelty-confering feature before the EPO.
Our Pharma and Life Sciene Day is a fantastic opportunity to discuss the most recent trends in pharma and life sciences in a relaxed environment with your peers from industry.
We are happy to welcome you to our reception at the Seehaus Englischer Garten afterwards.
We are pleased that the well-known Dusseldorf IP law firm Arnold Ruess supports the 2019 Pharmadays.
We are pleased that the well-known Swiss IP law firm Meyerlustenberger-Lachenal supports the Pharmadays 2019.